# PLA toxicity studies Topic radar · 323 documents · 2021-01-01–2026-11-02 · updated 2026-10-31 Canonical: https://slate.greyb.com/radar/pla-toxicity-studies/innovations ## In one minute ### Two polymerisation routes, and they fail differently The polymer is made either by ring-opening polymerisation of lactide or by polycondensing lactic acid directly, and the choice decides what has to be cleaned out afterwards. A Tianjin route runs the direct condensation in three stages: zinc-catalysed dehydration to oligomer, organic-guanidine melt polycondensation to a prepolymer, then solid-phase polycondensation on ground powder to build molecular weight [1]. A one-pot alternative heats lactic acid to 80–100 °C with food-grade zinc acetate dihydrate at 1% or more of substrate mass, letting the same zinc ion do both the dehydration and the lactide ring-opening by coordination-insertion [2]. The ring-opening route needs purified lactide first — one filing recrystallises it from a 30:1 to 50:1 lactic-acid-to-catalyst mix before polymerising under continuous vacuum [3]. The engineering consequence is that the direct route carries water and oligomer distribution as its hard problems, while the ring-opening route carries monomer purity and catalyst residue. Both end at the same place: a residue specification the device maker inherits. 1. [CN113150254A](/?paper=CN113150254A&utm_source=radar&utm_medium=dashboard) 2. [CN122080370A](/?paper=CN122080370A&utm_source=radar&utm_medium=dashboard) 3. [CN119371644A](/?paper=CN119371644A&utm_source=radar&utm_medium=dashboard) ### The safety case is filed as a composition, not as a test Almost the whole commercial argument in this field is made in catalyst patents, and it is made as a composition claim rather than a toxicological one. A magnesium centre on a biguanide is offered at 10.1 kg/mol with a dispersity of 1.44; a crown-imine phenoxy potassium complex is built to hold isotactic selectivity while lowering ligand toxicity; a trimetallic system, a salen-type metal alkoxide, a zinc-yttrium mixture and a metal-free diazomethane-alcohol pair that targets a 10 ppm heavy-metal limit all repeat the same justification. No filing in this set reports a cytotoxicity assay, an extractables panel or a leachables figure for the polymer it produces. What a buyer is handed is a molecular weight, a dispersity and, at best, a metal ceiling. ### Chemistry effort concentrates upstream, and the safety claim rides along with it The invention moving through this field is largely about which metal sits at the centre of the polymerisation and how the ligand around it is built. Zinc and yttrium together, magnesium on a biguanide, potassium on a crown-imine, a trimetallic complex, a salen-type alkoxide, and two routes that abandon metals altogether all arrive at the same stated justification: no tin residue, therefore safer for medical and food use. A separate school accepts the tin and cleans afterwards, saying so in the title, or keeps stannous octoate and changes the initiator to food-grade lactic acid. ### The catalyst programme is ligand design, not filtration Substitution work targets the ligand rather than the metal's removal. A magnesium centre held by a biguanide ligand is reported to give 10.1 kg/mol with a dispersity of 1.44 under mild preparation; a crown-imine phenoxy potassium complex is built to hold isotactic selectivity while lowering ligand toxicity. A trimetallic system and a salen-type metal alkoxide complex take the same approach from different directions. Two routes drop metals entirely: a diazomethane-alcohol pair aimed at the ≤10 ppm heavy-metal limit for implants, and a Lewis acid–base pair run at 130–180 °C for 0.25 to 24 hours. ### Where industry does answer, it answers persistence rather than release The substantial producer-side technical argument is a commissioned meta-study concluding that hydrolysis prevents persistent PLA microplastics from forming in the open environment, circulated by press release and trade coverage. The trade association's rebuttal of the Gothenburg paper-cup work makes the same move: it disputes attribution and the handling of biodegradability rather than the measured effect. ### The load-bearing work has shifted to the dissolved fraction, and it is method-building The productive line in this field is no longer the particle. Sequence-defined oligomer standards and a deuterated internal standard were synthesised so that oligomers could be quantified in soil at all, which turned an assumption into a number and put field residues under PLA mulch film at 16.10 ± 0.37 ng/g. Leachates were shown to carry 54.0 to 91.7% of PLA's effect on duckweed while the particles carried the rest. In kidney, the oligomeric fraction accumulated far above the polymer and drove inflammation through a receptor loop that could be blocked. ### Molecular weight is set by the initiator, and that is the medical-grade lever Because ring-opening polymerisation is initiator-limited, the alcohol chosen sets chain length and end-group. One medical grade keeps stannous octoate and changes only the initiator to 50–90% lactic acid, on the reasoning that this avoids the toxicity and instability of polyethylene glycol or dodecanol. The purified-lactide route uses dodecanol or p-toluenesulfonic acid as the initiator under −0.1 MPa, again with the claim that what matters is what stays in the chain. ### The only cleared commercial proposition here is an additive The one clearance in this field that attaches directly to the safety story is CARBIOS Active, an enzymatic additive introduced during conversion that makes PLA compostable at ambient temperature. It was listed in the FDA's Inventory of Effective Food Contact Substances under FCN 2325 and is marketed on the claim that the process leaves no toxic residues or microplastics behind. ## Overview ### The polymer clears its tests; the formulation and the breakdown products carry the risk Set the five bodies of work side by side and one structure holds across all of them. Unloaded polylactic acid is tolerated almost everywhere it is put: by osteoblasts on a drug-loaded membrane, by gingival and pre-osteoblast cells on a composite film, by fibroblasts on a salt-modified mat. Where the biology turns adverse, the cause traces to an additive, a payload, a filler surface or a manufacturing step. Scaffolds of the same polymer in white and translucent grades drew different tissue reactions in rats, so a colourant changed the outcome. A quaternary ammonium salt added to kill bacteria produced no antibacterial activity at all. Zinc-containing films read as clean on diluted extract and killed most cells on the undiluted one. The graphene composite kept every cell line adhering and proliferating while fibroblasts shed 34.38% debris against 5.93% in controls. ## What's new The month's four items press one point from different directions. In orchard soil, PLA microplastics raised carbon dioxide and nitrous oxide, while polyethylene and PET suppressed the same gases in the same experiment. In rainbow trout, PLA particles disrupted immune defences and changed blood cells, and sunlight weathering made the damage worse. In the clinic, a review dated 29 October found standard PLA deformed after hydrogen peroxide sterilization and most materials badly deformed by autoclaving. ## Research ### Reactive extrusion trades migration for melt strength The processing fix for PLA's poor melt strength is peroxide branching, and the chemistry is chosen for what it leaves behind. A dicarbonate peroxide is specified because it decomposes mainly to carbon dioxide, keeping the resin acceptable for food contact at 95.2–99.83% PLA content. A cyclic peroxide paired with acrylates — triallyl isocyanurate, butanediol diacrylate or trimethylolpropane triacrylate — is used instead of linear peroxides to suppress gelation and volatile residues, giving a polydispersity of 2.0–3.0 and a Vicat softening point of 150–170 °C. ### Fibre formation has moved past the single-needle bath The dressing work is built on competing fibre processes, and the comparison is instructive. Electrospinning and air-jet spinning of 10% PLA with ibuprofen at 10–30% produced scaffolds with the same sustained release over 384 hours, but the air-jet fibres were more uniform in diameter. Air-jet spinning also tolerates ceramic loading: SBA-15 at 0.05–0.15 wt% increases fibre diameter dose-dependently, giving a handle on morphology that solution conductivity alone does not. Centrifugal spinning produces PLA/BaTiO₃ fibres without a high-voltage field, and the filler's effect on bacteria survives UV/ozone ageing. ### Printing turns formulation into a geometry problem Fused-filament fabrication is the dominant shaping route in this set, and the process variables act as material variables. Cross-patterned scaffolds printed at 50–70% infill and heat-treated at 90 °C for 120 minutes gain crystallinity, roughly 20% higher yield strength, and better osteoblast viability over 15 days than untreated prints. Steam sterilisation at 121 °C for 15 minutes and recycling both make deformation less predictable, with infill rate dominating flexural strength. ### Fillers are doing degradation chemistry, not just reinforcement The most interesting composites are formulated around the acid problem. Fused-deposition PLA with 0.5–2 wt% magnesium hydroxide and 5 wt% nano-hydroxyapatite drops contact angle from 71.5° to 49.7°, lifts 60-day weight loss from about 2% to 15.52%, buffers local acidity, and raises compressive strength from 9.37 to 27.55 MPa — with MG-63 viability at 98.36% at the low loading and 88.76% at the highest. A thermally induced phase separation route makes 86–97% porous foams with 10–85 µm interconnected pores, then modifies them in alkali and chitosan to raise wettability and degradation in simulated saliva. ### Encapsulation puts the active agent behind a carrier Rather than raise dose, the field holds the agent in a structure. Silver can be reduced in situ inside cyclodextrin metal-organic frameworks to 1–2 nm particles at 0.05–3.01 wt% loading, then cast into PLA films with polyethylene glycol. The engineering claim is that the carrier, not the silver, sets the release rate and therefore the toxicological question. ### Surface chemistry is the last step before biology Several routes treat the interface after shaping. A two-stage modification — low-temperature nitrogen plasma arc discharge followed by immobilisation of hyaluronic acid — raises surface energy and lowers water contact angle without introducing cytotoxicity. Laponite coated at 0.8 wt% onto electrospun PLA improves hydrophilicity and holds mesenchymal stem cell viability to 72 hours. Strontium carbonate at 4% on printed scaffolds gives the most uniform coating and the highest osteoblast viability in the series, and sodium hydroxide treatment of PLA/akermanite composites opens the surface for cell attachment. ### Sterilisation is a chemical step, not a packaging step Heat, gamma and ethylene oxide sterilisation can degrade PLA and release toxic products, because the polymer is thermally and hydrolytically sensitive. This is the process step most likely to be inherited unchanged from metal-device practice and least likely to be validated for a resorbable polyester. On the printing side the same logic applies to the air: 62 volatile organic compounds have been identified across material-extrusion printing, with emission rates varying by filament composition, additives, temperature and whether the printer is enclosed. ### What the engineering has not built There is no process here that removes the acid load; buffering is added as a filler, in a window measured in weeks. And no construction in this set has been tested for what it releases across its own service life — the longest implant observation runs nine months, while the release measurements are made on simulants at hours to days. ## Market ### Volume is arriving ahead of any differentiation The supply side is expanding into a price collapse. An industry analysis of Chinese biodegradable plastics reports effective capacity far above actual output, utilisation below 40%, and prices well under their 2021 peaks, with mature routes constrained upstream by lactide supply; it credits the established Western producers with competing on patents and quality rather than tonnage. That reading is confirmed at company level. The longest-established PLA producer is divesting its stake in the PLA joint venture to refocus on food ingredients, while the principal US producer has petitioned for tariffs on imported resin and on downstream products including 3D-printing filament and foodservice ware. Independent tracking has bio-based polymer capacity growing at double digits through 2029 with PLA the largest share. ### One study shows what a supportable claim would look like The template exists, and it is not being used. A PLA fibre safety assessment took a finished consumer article — underwear padding — and ran non-targeted screening against toxicological risk scoring, producing a substance-level judgement about a product rather than about a polymer. That is the shape of a marketing claim that survives scrutiny: a named article, an identified migrant list, and a scored exposure judgement. ## Strategy ### One programme is turning degradation state into an experimental variable, and its own results disagree The most organised effort in the set treats polymer and oligomer as separate test articles and runs the same design organ by organ: kidney via the scavenger receptor pathway, liver via gut microbiota and uric acid, intestine in fish through mitochondrial dysfunction. This is the closest thing here to a systematic safety assessment of a degradable material, and it comes largely from groups attached to a medical-products regulator. ### Injectable aesthetics is pulling filings toward the one use with a documented late failure The newest chemistry filing in this set is not a device or a package. It is a modified PLLA for medical-beauty injection, and its stated purpose is to avoid the biological toxicity of stannous octoate by building the catalyst from manganese, chromium, titanium, zinc and tin oxides. I would flag the composition rather than the claim. A filing whose whole justification is the removal of tin arrives with tin oxide still in the catalyst, and chromium oxide alongside it. ### The pieces of a device-level safety file exist, assembled nowhere Set side by side, the components are there and disconnected. Degradation-state standards exist in environmental chemistry. A druggable mechanistic handle for the inflammatory response to oligomer exists in immunology. Migration cells and simulant protocols exist in food contact, and the regulator is tightening toward composition-level control of exactly those substances rather than finished-article testing alone. Meanwhile the implant filings argue kinetics, matching filler breakdown to polymer breakdown, which is a safety argument expressed in mechanical language. ## Areas - Biomedical Implants & Tissue Engineering · 122 documents - Environmental Micro/Nanoplastic Pollution · 101 documents - Synthesis, Processing & End-of-Life · 60 documents - Food Contact & Packaging · 31 documents - Consumer, Cosmetic & General Safety · 5 documents